National Cancer Institute - Cancer.gov

CCR Leadership

Senior Management Team

James Gulley
Acting Co-Director, James L. Gulley, M.D., Ph.D.
headshot of Glenn Merlino
Acting Co-Director, Glenn Merlino, Ph.D.
 

Learn more about the Office of the Director

Deputy Directors

Headshot of Deb Citrin

Deborah E. Citrin, M.D.

Mark Gilbert

Mark R. Gilbert, M.D.

Tim Greten

Tim F. Greten, M.D.

Mary Kearney

Mary F. Kearney, Ph.D.

Stanley Lipkowitz

Stanley Lipkowitz, M.D., Ph.D.

Daniel W. McVicar, Ph.D..

Beverly Mock, Ph.D.

Joel P. Schneider, Ph.D.

Carol J. Thiele, Ph.D.

Xin Wei Wang

Xin Wei Wang, Ph.D.

 

Office of the Clinical Director

Clinical Director

James L. Gulley, M.D., Ph.D.

Deputy Clinical Director 

Fatima Karzai, M.D.

Director, Medical Oncology Service

Arun Rajan, M.D.

Associate Director, Patient Outcomes

Terri S. Armstrong, Ph.D., ANP-BC, FAAN, FAANP

Learn more about the Office of the Clinical Director

CCR Science Board

Natasha Caplen

Chair, CSB
Natasha J. Caplen, Ph.D.

The purpose of the Center for Cancer Research (CCR) Science Board (CSB) is to establish a venue to provide input from the intramural community to the Director, CCR, on scientific and technology programs and strategies. In particular, the CSB oversees and develops non-principal investigator-based programs within the CCR. The CSB is complementary to the Board of Scientific Counselors (BSC) in that it does not review the base resource allocations of individual PIs or Laboratories/Branches. Input from the CSB will be considered by the Director in combination with feedback and suggestions from other components of CCR, the BSC and NCI leadership.